Qirong Geng

XELOX doublet regimen versus EOX triplet regimen as first‐line treatment for advanced gastric cancer: An open‐labeled, multicenter, randomized, prospective phase III trial (EXELOX)

Yi He, Wen-hua Li, J. Ying, 2022, Cancer communications.

ASTE1 frameshift mutation triggers the immune response in Epstein-Barr virus-associated gastric cancer

Shenglin Huang, Dazhi Xu, Qin Li, 2022, Signal Transduction and Targeted Therapy.

AKP and GGT level can provide early prediction of first-line treatment efficacy in colorectal cancer patients with hepatic metastases.

Mingzhu Huang, Wen-hua Li, Wen Zhang, 2021, Biomarkers in medicine.

Apatinib for patients with metastatic biliary tract carcinoma refractory to standard chemotherapy: results from an investigator-initiated, open-label, single-arm, exploratory phase II study

Jinjia Chang, Mingzhu Huang, Wen-hua Li, 2021, Therapeutic advances in medical oncology.

Induction Chemotherapy Followed by Primary Tumor Resection Did Not Bring Survival Benefits in Colon Cancer Patients With Asymptomatic Primary Lesion and Synchronous Unresectable Metastases

Xinxiang Li, Sijie Sun, Xiaodong Zhu, 2022, Frontiers in Oncology.